{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:36:06Z","timestamp":1794490566677,"version":"4.9.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biopha.2020.110393","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T12:21:05Z","timestamp":1592310065000},"page":"110393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":225,"special_numbering":"C","title":["Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect"],"prefix":"10.1016","volume":"129","author":[{"given":"Jiansong","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2020.110393_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.urology.2016.05.041","article-title":"Bladder preservation therapy: a review of the literature and future directions","volume":"96","author":"Cahn","year":"2016","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2020.110393_bib0020","article-title":"Discrepancy between European association of urology guidelines and daily practice in the management of non-muscle-invasive bladder Cancer: results of a european survey","author":"Hendricksen","year":"2017","journal-title":"Eur. Urol. Focus"},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1969.101","article-title":"Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells","volume":"23","author":"Math\u00e9","year":"1969","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0030","first-page":"891","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"167","author":"Morales","year":"1976","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110393_bib0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.revmed.2014.10.361","article-title":"Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy","volume":"36","author":"Raffray","year":"2015","journal-title":"Rev. Roum. Med. Intern."},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pjnns.2015.12.003","article-title":"Spinal tuberculosis with severe neurological symptoms as a complication of intravesical BCG therapy for carcinoma of the bladder","volume":"50","author":"Bia\u0142ecki","year":"2016","journal-title":"Neurologia I Neurochirurgia Polska"},{"issue":"8","key":"10.1016\/j.biopha.2020.110393_bib0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jjco\/hyt086","article-title":"Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder Cancer","volume":"43","author":"Miyazaki","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"Suppl 21","key":"10.1016\/j.biopha.2020.110393_bib0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5301\/RU.2013.10861","article-title":"[Adverse events after intravesical therapy: are we always ready to recognize and prevent them?]","volume":"80","author":"Fiorito","year":"2013","journal-title":"Urologia"},{"issue":"8","key":"10.1016\/j.biopha.2020.110393_bib0055","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cncr.22588","article-title":"PD\u2010L1 (B7\u2010H1) expression by urothelial carcinoma of the bladder and BCG\u2010induced granulomata","volume":"109","author":"Inman","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2020.110393_bib0060","first-page":"1","article-title":"Cancer immune therapy: prognostic significance and implications for therapy of PD-1 in BCG-Relapsing bladder cancer","author":"Mukherjee","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110393_bib0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biopha.2007.05.004","article-title":"Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement","volume":"61","author":"Brandau","year":"2007","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/01913123.2011.620221","article-title":"Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy","volume":"36","author":"Ajili","year":"2012","journal-title":"Ultrastruct. Pathol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110393_bib0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.kjms.2015.05.005","article-title":"Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation","volume":"31","author":"Yu","year":"2015","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2020.110393_bib0080","first-page":"823","article-title":"Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus calmette-Gu\u00e9rin in transitional cancer cell lines","volume":"20","author":"Sandes","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1476-4598-13-210","article-title":"Mycobacterium bovis, BCG promotes tumor cell survival from tumor necrosis factor-\u03b1-induced apoptosis","volume":"13","author":"Sahana","year":"2014","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2020.110393_bib0090","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1464-410X.2008.08274.x","article-title":"Bacille-Calmette Gu\u00e8rin induces caspase\u2010independent cell death in urothelial carcinoma cells together with release of the necrosis\u2010associated chemokine high molecular group box protein 1","volume":"103","author":"See","year":"2010","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12514","article-title":"Melatonin and its metabolites versus oxidative stress: from individual actions to collective protection","volume":"65","author":"Galano","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2020.110393_bib0100","first-page":"6","article-title":"Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes","author":"Ryk","year":"2015","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12885-018-4107-1","article-title":"Oxidative damage and response to Bacillus calmette-Gu\u00e9rin, in bladder cancer cells expressing sialyltransferase ST3GAL1","volume":"18","author":"Severino","year":"2018","journal-title":"BMC Cancer"},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110393_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2014.03.014","article-title":"Secondary stimulation from Bacillus calmette-Gu\u00e9rin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells","volume":"348","author":"Thiel","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0115","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.juro.2014.05.115","article-title":"H2O2 generation by BCG induces the cellular oxidative stress response required for BCG\u00e2\u25a1\u2122s direct effects on urothelial carcinoma tumor biology","volume":"192","author":"Shah","year":"2014","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urolonc.2013.06.005","article-title":"iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology","volume":"32","author":"Shah","year":"2014","journal-title":"Urol. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110393_bib0125","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.18632\/oncotarget.1494","article-title":"1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Gu\u00e9rin immunotherapy of bladder cancer","volume":"4","author":"Hsu","year":"2013","journal-title":"Oncotarget"},{"issue":"Suppl. (2)","key":"10.1016\/j.biopha.2020.110393_bib0130","first-page":"1","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110393_bib0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer--a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cas.12075","article-title":"Bacillus Calmette\u2013Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0150","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.juro.2007.11.045","article-title":"The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study","volume":"179","author":"Pan","year":"2008","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0155","first-page":"181","article-title":"BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines","volume":"9","author":"Bevers","year":"1998","journal-title":"Eur. Cytokine Netw."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0160","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.urology.2014.12.028","article-title":"Modulating the internalization of bacille Calmette-Guerin by cathelicidin in bladder cancer cells","volume":"85","author":"Choi","year":"2015","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0165","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-5347(05)68633-8","article-title":"Bacillus-Calmette-Gu\u00e9rin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion","volume":"162","author":"Durek","year":"1999","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2172-4-5","article-title":"Genetic control of the innate immune response","volume":"4","author":"Wells","year":"2003","journal-title":"BMC Immunol."},{"issue":"25","key":"10.1016\/j.biopha.2020.110393_bib0175","doi-asserted-by":"crossref","first-page":"23065","DOI":"10.1074\/jbc.M011660200","article-title":"Mycobacterium bovis Bacillus calmette-Guerin and its cell wall complex induce a novel lysosomal membrane protein, SIMPLE, that bridges the missing link between lipopolysaccharide and p53-inducible gene, LITAF(PIG7), and estrogen-inducible gene, EET-1","volume":"276","author":"Moriwaki","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.0603280","article-title":"Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65\/p300 binding","volume":"75","author":"Darieva","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2020.110393_bib0185","first-page":"8","article-title":"Deconvolution of the response to Bacillus Calmette\u2013Gu\u00e9rin reveals NF-\u03baB-Induced cytokines as autocrine mediators of innate immunity","author":"Bisiaux","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110393_bib0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11655-010-0787-y","article-title":"The regulatory effects of Polyporus polysaccharide on the nuclear factor kappa B signal pathway of bladder Cancer cells stimulated by Bacillus calmette-Guerin","volume":"17","author":"Wei","year":"2011","journal-title":"Chin. J. Integr. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellimm.2013.11.007","article-title":"BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9","volume":"287","author":"Bakhru","year":"2014","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1442-2042.2002.00415.x","article-title":"Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guerin (BCG): a role of BCG internalization into tumor cells","volume":"9","author":"Ikeda","year":"2010","journal-title":"Int. J. Urol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110393_bib0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urolonc.2014.09.016","article-title":"TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells","volume":"33","author":"Olbert","year":"2015","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.eururo.2015.06.023","article-title":"Cytokine Panel for Response to Intravesical Therapy (CyPRIT): nomogram of changes in urinary cytokine levels predicts patient response to bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Kamat","year":"2016","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110393_bib0215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1464-410X.2012.11754.x","article-title":"Bacillus Calmette\u2010Gu\u00e9rin immunotherapy for genitourinary cancer","volume":"112","author":"Ghi","year":"2013","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0220","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1464-410X.2006.06026.x","article-title":"Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Gu\u00e9rin through Toll-like receptor signalling","volume":"97","author":"Miyazaki","year":"2010","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.biopha.2020.110393_bib0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01741551","article-title":"Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Gu\u00e9rin in superficial bladder cancer","volume":"34","author":"De Boer","year":"1992","journal-title":"Cancer Immunol. Immunother."},{"issue":"default","key":"10.1016\/j.biopha.2020.110393_bib0230","first-page":"65","article-title":"Immunotherapy for bladder cancer","volume":"7","author":"Fuge","year":"2015","journal-title":"Res. Rep. Urol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110393_bib0235","first-page":"611","article-title":"Novel insights into the mechanism of action of intravesical immunomodulators","volume":"19","author":"Mitropoulos","year":"2005","journal-title":"Vivo"},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00262-016-1945-z","article-title":"Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer","volume":"66","author":"Pichler","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.biopha.2020.110393_bib0245","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.eururo.2017.11.021","article-title":"The current state of predicting response on Bacillus Calmette-Gu\u00e9rin treatment for nonmuscle invasive bladder Cancer is not yet useful for patients but attributes to understanding its mechanisms of action","volume":"73","author":"Oddens","year":"2018","journal-title":"Eur. Urol."},{"issue":"1-3","key":"10.1016\/j.biopha.2020.110393_bib0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12026-007-0084-1","article-title":"Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer","volume":"39","author":"Simons","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biopha.2020.110393_bib0255","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mehy.2017.05.011","article-title":"Granulocytes as an effector mechanism of BCG therapy for bladder cancer","volume":"104","author":"Rd","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"5","key":"10.1016\/j.biopha.2020.110393_bib0260","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0022-5347(05)67678-1","article-title":"Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the alpha5beta1 firbonectin receptor","volume":"163","author":"Zhang","year":"2000","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110393_bib0265","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","article-title":"IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection","volume":"178","author":"Umemura","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.110393_bib0270","series-title":"Miscellaneous Approaches and Considerations: TLR Agonists and Other Inflammatory Agents, Anti-Chemokine Agents, Infectious Agents, Tumor Stroma Targeting, Age and Sex Effects, and Miscellaneous Small Molecules","first-page":"399","author":"Svatek","year":"2013"},{"issue":"3-4","key":"10.1016\/j.biopha.2020.110393_bib0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10555-009-9195-6","article-title":"The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guerin (BCG) immunotherapy for urothelial carcinoma of the bladder","volume":"28","author":"Rosevear","year":"2009","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.biopha.2020.110393_bib0280","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.semcancer.2013.02.002","article-title":"PMN and anti-tumor immunity\u2014the case of bladder cancer immunotherapy","volume":"23","author":"Brincks","year":"2013","journal-title":"Semin. Cancer Biol."},{"issue":"17","key":"10.1016\/j.biopha.2020.110393_bib0285","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","article-title":"TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL","volume":"16","author":"Walczak","year":"2014","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00281-007-0073-4","article-title":"Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia?","volume":"29","author":"Gupta","year":"2007","journal-title":"Semin. Immunopathol."},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110393_bib0295","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2014.03.014","article-title":"Secondary stimulation from Bacillus Calmette-Gu\u00e9rin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells","volume":"348","author":"Thiel","year":"2014","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.biopha.2020.110393_bib0300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0305","first-page":"14","article-title":"A review of the PD-1\/PD-L1 checkpoint in bladder cancer: from mediator of immune escape to target for treatment","volume":"35","author":"Zhou","year":"2017","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0310","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000165","article-title":"Checkpoint inhibitors in the treatment of urological malignancies","volume":"2","author":"Popovic","year":"2017","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.biopha.2020.110393_bib0315","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110393_bib0320","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.7314\/APJCP.2014.15.3.1321","article-title":"Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.biopha.2020.110393_bib0325","article-title":"Adaptive immune resistance to intravesical BCG in non-muscle invasive bladder Cancer: implications for prospective BCG unresponsive trials","author":"Kates","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0330","first-page":"354","article-title":"Comparison between BCG strains of different origins: observations concerning BCG strains of Brazilian origin (Moreau strain)","volume":"33","author":"Kurylowicz","year":"1957","journal-title":"Acta Tuberc. Scand."},{"issue":"38","key":"10.1016\/j.biopha.2020.110393_bib0335","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2016.07.022","article-title":"Different effects of BCG strains \u2013 a natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau","volume":"34","author":"Frankel","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0340","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mt.2015.216","article-title":"Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms","volume":"24","author":"Lu","year":"2016","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2020.110393_bib0345","article-title":"1672 A randomized phase III study comparing immucysT\u00ae versus oncotice\u00ae the BCG strain used makes a difference","volume":"187","author":"Birkhaeuser","year":"2012","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110393_bib0350","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.juro.2012.09.049","article-title":"Connaught and Russian strains showed the highest direct antitumor effects of different Bacillus Calmette-Gu\u00e9rin substrains","volume":"189","author":"Secanella-Fandos","year":"2013","journal-title":"J. Urol."},{"issue":"1039","key":"10.1016\/j.biopha.2020.110393_bib0355","article-title":"Magnetic delivery of Fe3O4@polydopamine nanoparticle-loaded natural killer cells suggest a promising anticancer treatment","volume":"10","author":"Liya","year":"2018","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110393_bib0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2013.12.027","article-title":"Nanoparticulation of BCG-CWS for application to bladder cancer therapy","volume":"176","author":"Nakamura","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2020.110393_bib0365","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3389\/fphar.2017.00977","article-title":"Nano-BCG: a promising delivery system for treatment of human bladder cancer","volume":"8","author":"Huch","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:58:34Z","timestamp":1760097514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220305862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":73,"alternative-id":["S0753332220305862"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110393","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110393"}}